$28.14
-0.66-2.29%
At close: -
$28.14
0.000.00%
After Hours: 4:00 PM EDT
Castle Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Castle Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $0.08 | $-0.06 | 233.3 % |
Jun 2024 | 2024-08-05 | $0.31 | $-0.29 | 206.9 % |
Mar 2024 | 2024-05-02 | $-0.09 | $-0.33 | 72.7 % |
Dec 2023 | 2024-02-28 | $-0.10 | $-0.54 | 81.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $85.78M | $79.84M | 7.44 % |
Jun 2024 | 2024-08-05 | $87.00M | $69.08M | 25.9 % |
Mar 2024 | 2024-05-02 | $72.97M | $66.20M | 10.2 % |
Dec 2023 | 2024-02-28 | $66.12M | $56.28M | 17.5 % |
Castle Biosciences (CSTL) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
The Actual EPS was $0.08, which beat the estimate of $-0.06.
The Actual Revenue was $85.8M, which beat the estimate of $79.8M.
Browse earnings estimates, EPS, and revenue on all stocks.